Topics

STAT Plus: 4 questions key to making sense of new data on Biogen’s resurrected Alzheimer’s drug

04:30 EST 4 Dec 2019 | STAT

Here are four questions key to making sense of new data on Biogen’s resurrected Alzheimer’s drug ahead of a highly anticipated presentation.

Original Article: STAT Plus: 4 questions key to making sense of new data on Biogen’s resurrected Alzheimer’s drug

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: 4 questions key to making sense of new data on Biogen’s resurrected Alzheimer’s drug"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...